These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11523339)

  • 1. Monitoring the antiplatelet action of aspirin.
    Fritsma GA; Ens GE; Alvord MA; Carroll AA; Jensen R
    JAAPA; 2001 May; 14(5):57-8, 61-2. PubMed ID: 11523339
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terms and conditions: semantic complexity and aspirin resistance.
    Hennekens CH; Schror K; Weisman S; FitzGerald GA
    Circulation; 2004 Sep; 110(12):1706-8. PubMed ID: 15381661
    [No Abstract]   [Full Text] [Related]  

  • 5. Can platelet function tests predict the clinical efficacy of aspirin?
    Haubelt H; Anders C; Hellstern P
    Semin Thromb Hemost; 2005; 31(4):404-10. PubMed ID: 16149017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin resistance.
    Tran HA; Anand SS; Hankey GJ; Eikelboom JW
    Thromb Res; 2007; 120(3):337-46. PubMed ID: 17241655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aspirin resistance controversy: clinical entity or platelet heterogeneity?
    Freedman JE
    Circulation; 2006 Jun; 113(25):2865-7. PubMed ID: 16801473
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of aspirin-induced decrease in thrombin formation in subjects resistant to aspirin.
    Undas A; Placzkiewicz-Jankowska E; Zieliński L; Tracz W
    Thromb Haemost; 2007 Jun; 97(6):1056-8. PubMed ID: 17549314
    [No Abstract]   [Full Text] [Related]  

  • 10. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population.
    Faraday N; Becker DM; Yanek LR; Herrera-Galeano JE; Segal JB; Moy TF; Bray PF; Becker LC
    Am J Cardiol; 2006 Sep; 98(6):774-9. PubMed ID: 16950183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monitoring of antiplatelet drug effects--fashion or necessity?].
    Kuliczkowski W; Zembala M; Poloński L; Kaczmarski J; Gasior M
    Kardiol Pol; 2008 Jan; 66(1):119-24. PubMed ID: 18266199
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance to antiplatelet therapy: fact or fiction?
    Wong S; Lewis D
    N Z Med J; 2005 May; 118(1215):U1459. PubMed ID: 15915183
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical importance of aspirin resistance].
    Hirmerová J; Filipovský J
    Vnitr Lek; 2004 Jun; 50(6):462-9. PubMed ID: 15346640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of aspirin response measured by urinary 11-dehydrothromboxane B2 and VerifyNow aspirin assay in patients with ischemic stroke.
    Dharmasaroja PA; Sae-Lim S
    J Stroke Cerebrovasc Dis; 2014; 23(5):953-7. PubMed ID: 24126290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin resistance following pediatric cardiac surgery.
    Cholette JM; Mamikonian L; Alfieris GM; Blumberg N; Lerner NB
    Thromb Res; 2010 Sep; 126(3):200-6. PubMed ID: 20550971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease.
    Renda G; Tacconelli S; Capone ML; Sacchetta D; Santarelli F; Sciulli MG; Zimarino M; Grana M; D'Amelio E; Zurro M; Price TS; Patrono C; De Caterina R; Patrignani P
    Clin Pharmacol Ther; 2006 Sep; 80(3):264-74. PubMed ID: 16952493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and clopidogrel resistance-a myth or reality: an update.
    Gupta S; Gupta MM
    Indian Heart J; 2008; 60(3):245-53. PubMed ID: 19240315
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug insight: aspirin resistance--fact or fashion?
    Patrono C; Rocca B
    Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):42-50. PubMed ID: 17180149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin response variability assessed with the PFA-100 device.
    Reny JL; Quéré I; de Moerloose P; Fontana P
    Thromb Haemost; 2008 May; 99(5):968-9; author reply 969. PubMed ID: 18449432
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.